Vimarsana
Biggest News Aggregation in the World

Page 20 - Cipla Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cipla Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cipla Ltd Today - Breaking & Trending Today

share market: Share market update: Most active stocks in today's market in terms of volume - Vimarsana News

share market: Share market update: Most active stocks in today's market in terms of volume

The NSE Nifty index closed 111.05 points up at 22753.8

Indian Pharma Market Booms: 9.5% Growth in March 2024 - Vimarsana News

Indian Pharma Market Booms: 9.5% Growth in March 2024

Leading therapies like cardiac, anti-infectives, and gastro-intestinal recorded robust volume growth in MAT figures, constituting 37.5% of IPM.

Indices: Stock market update: Nifty Pharma index advances 0.44% in an upbeat market - Vimarsana News

Indices: Stock market update: Nifty Pharma index advances 0.44% in an upbeat market

The Nifty Pharma index was trading 0.44 per cent up at 19245.65.

Stock Market Sectors: Stock market update: Sugar stocks down as market rises - Vimarsana News

Stock Market Sectors: Stock market update: Sugar stocks down as market rises

The 30-share BSE Sensex was up 366.13 points at 74614.35

Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot - Vimarsana News

Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot

Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.